Literature DB >> 31891668

Multifocal and multicentric breast cancer, is it time to think again?

Y A Masannat1,2, A Agrawal3, L Maraqa4, M Fuller1,2, S K Down5,6, Ssk Tang7, D Pang1, M Kontos8, L Romics9, S D Heys1,2.   

Abstract

Multifocal multicentric breast cancer has traditionally been considered a contraindication to breast conserving surgery because of concerns regarding locoregional control and risk of disease recurrence. However, the evidence supporting this practice is limited. Increasingly, many breast surgeons are advocating breast conservation in selected cases. This short narrative review summarises current evidence on the role of surgery in multifocal multicentric breast cancer and shows that when technically feasible the option of breast conservation is oncologically safe.

Entities:  

Keywords:  Breast conserving surgery; Mastectomy; Multicentric; Multifocal; Oncoplastic surgery; breast cancer

Mesh：

Year:  2019        PMID： 31891668      PMCID： PMC6937617          DOI： 10.1308/rcsann.2019.0109

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  31 in total

1.  Immediate transposition of a latissimus dorsi muscle for correcting a postquadrantectomy breast deformity in Japanese patients.

Authors:  M Noguchi; T Taniya; I Miyazaki; Y Saito
Journal:  Int Surg       Date:  1990 Jul-Sep

Review 2.  Use of boost radiotherapy in oncoplastic breast-conserving surgery - a systematic review.

Authors:  M V Schaverien; S Stallard; D Dodwell; J C Doughty
Journal:  Eur J Surg Oncol       Date:  2013-08-26       Impact factor: 4.424

3.  How to compare the oncological safety of oncoplastic breast conservation surgery - To wide local excision or mastectomy?

Authors:  J Mansell; E Weiler-Mithoff; J Martin; A Khan; S Stallard; J C Doughty; L Romics
Journal:  Breast       Date:  2015-05-23       Impact factor: 4.380

4.  Surgical treatment of multiple ipsilateral breast cancers.

Authors:  Z E Winters; J R Benson
Journal:  Br J Surg       Date:  2018-02-07       Impact factor: 6.939

5.  The use of latissimus dorsi miniflap for reconstruction following breast-conserving surgery: experience of a small breast unit in a district hospital.

Authors:  C Navin; A Agrawal; K M Kolar
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

6.  Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.

Authors:  R Wolters; A Wöckel; W Janni; I Novopashenny; F Ebner; R Kreienberg; M Wischnewsky; L Schwentner
Journal:  Breast Cancer Res Treat       Date:  2013-11-21       Impact factor: 4.872

7.  The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.

Authors:  Kari M Rosenkranz; Karla Ballman; Linda McCall; Charlotte Kubicky; Laurie Cuttino; Huong Le-Petross; Kelly K Hunt; Armando Giuliano; Kimberly J Van Zee; Bruce Haffty; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2018-07-09       Impact factor: 5.344

8.  Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: a randomized placebo-controlled trial.

Authors:  Arie Levine; Michal Kori; Gabriel Dinari; Efrat Broide; Ron Shaoul; Baruch Yerushalmi; Avi On; Yoram Bujanover; Markus Pröls; Roland Greinwald
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

9.  Breast-conserving therapy for macroscopically multiple cancers.

Authors:  J M Kurtz; J Jacquemier; R Amalric; H Brandone; Y Ayme; D Hans; C Bressac; J M Spitalier
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

10.  Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery.

Authors:  R Holland; S H Veling; M Mravunac; J H Hendriks
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860
View more
  6 in total

1.  Oncoplastic surgery: A suitable alternative to conventional breast conserving surgery in low - Middle income countries; a retrospective cohort study.

Authors:  Syeda Sakina Abidi; Lubna Mushtaque Vohra; Muhammad Rizwan Javed; Nargis Khan
Journal:  Ann Med Surg (Lond)       Date:  2021-07-29

2.  Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients.

Authors:  Lei Feng; Lei Sheng; Litao Zhang; Na Li; Yuanzhong Xie
Journal:  Contrast Media Mol Imaging       Date:  2022-04-06       Impact factor: 3.009

3.  Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography.

Authors:  Melania Costantini; Rino Aldo Montella; Maria Paola Fadda; Vincenzo Tondolo; Gianluca Franceschini; Sonia Bove; Giorgia Garganese; Pierluigi Maria Rinaldi
Journal:  J Pers Med       Date:  2022-05-25

4.  A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland.

Authors:  Laszlo Romics; Julie Doughty; Sheila Stallard; James Mansell; Vivienne Blackhall; Alison Lannigan; Suzanne Elgammal; Judith Reid; Marie-Claire McGuigan; Francesca Savioli; Sian Tovey; Dermott Murphy; Iona Reid; Andy Malyon; Jennifer McIlhenny; Christopher Wilson
Journal:  Breast       Date:  2020-11-25       Impact factor: 4.380

5.  Dual-Layer Rotation: A Versatile Therapeutic Mammoplasty Technique.

Authors:  Sarianna Joukainen; Elina Laaksonen; Ritva Vanninen; Outi Kaarela; Mazen Sudah
Journal:  Ann Surg Oncol       Date:  2022-06-16       Impact factor: 4.339

6.  The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer.

Authors:  Andrzej Lorek; Katarzyna Steinhof-Radwańska; Anna Barczyk-Gutkowska; Wojciech Zarębski; Piotr Paleń; Karol Szyluk; Joanna Lorek; Anna Grażyńska; Paweł Niemiec; Iwona Gisterek
Journal:  Curr Oncol       Date:  2021-07-12       Impact factor: 3.677
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.